Diabetes Drugs Flashcards
(41 cards)
NPH (Neutral Protamin Hagedorn, Isophane) Insulin
Intermediate acting insulin
Rapid Acting Insulins (3)
Insulin Lispro
Insulin Aspart
Insulin Glulisine
Long acting Insulins (3)
Glargine
Detemir
Degludec
Inhalable Insulin (1)
Afrezza
Indications for insulin (diseases to use for)
- ß-cell failure: type I DM, pancreatitis, post-pancreatectomy
- type II DM after other meds fail
- Gestational DM
- Unstable diabetes- DKA, non-ketotic coma, hyperglycemia
Insulin side effects & drug interactions (3)
- Hypoglycemia
- para/sympathetic activity (GI, tachycardia, sweating, trembling, confusion, coma, convulsions)
- Weight gain
- Insulin allergy (rare)
Drugs:
- glucocorticoids
- oral contraceptives
- ß agonists/antagonists
10 diabetes med classes
1) Insulin secretagogues (
- sulfonylureas: glyburide, glipizide, glimepiride
- meglitinides (repaglinide, netaglinide)
2) Biguanides (metformin)
3) GLP-1 agonists (exenatide, liraglutide, lixisenatide, dulaglutide, albiglutide)
4) DPP-4 Inhibitors (sitagliptin, saxagliptin, linagliptin, alogliptin)
5) SGLT2 Inhibitors (Canagliflozin, dapagliflozin, empagliflozin)
6) Amylin agonists (pramlintide)
7) Thiazolidinediones (pioglitazone, rosiglitazone)
8) å-glucosidase inhibitors (acarbose, miglitol)
9) Bile Acid Binding Resins (Colesevelam)
10) Dopamine Receptor agonists (Bromocriptine)
Metformin (class, mechanism, use, side effects)
Class: Biguanide
Mechanism: decrease hepatic glucose output- anti-hyperglycemic but not hypoglycemic
Use: first line t2 DM
Side effects: GI disturbance, decreased B12 absorption
Sulfonylureas (drugs, mechanism, use, side effects, drug interactions)
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release
Drugs: glyburide, glipizide, glimepiride (gl-)
Use: T2 DM (need functional ß-cells)
Side effects: weight gain, hypoglycemia
Drug interactions: CYP3A4 inducers (barbiturates, rifampin) and glucocorticoids, oral contraceptives, thiazides, phenytoin, ß-agonists
Glyburide (class, mechanism, use, side effects, drug interactions)
Class: Sulfonylurea (insulin secretagogue)
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release
Use: T2 DM (need functional ß-cells)
Side effects: weight gain, hypoglycemia
Drug interactions: CYP3A4 inducers (barbiturates, rifampin) and glucocorticoids, oral contraceptives, thiazides, phenytoin, ß-agonists
Glipizide (class, mechanism, use, side effects, drug interactions)
Class: Sulfonylurea (insulin secretagogue)
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release
Use: T2 DM (need functional ß-cells)
Side effects: weight gain, hypoglycemia
Drug interactions: CYP3A4 inducers (barbiturates, rifampin) and glucocorticoids, oral contraceptives, thiazides, phenytoin, ß-agonists
Glimepiride (class, mechanism, use, side effects, drug interactions)
Class: Sulfonylurea (insulin secretagogue)
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release
Use: T2 DM (need functional ß-cells)
Side effects: weight gain, hypoglycemia
Drug interactions: CYP3A4 inducers (barbiturates, rifampin) and glucocorticoids, oral contraceptives, thiazides, phenytoin, ß-agonists
Meglitinides (class, drugs, mechanism, side effects)
Class: insulin secretagogue
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release (same as sulfonylureas but unrelated structure)
Drugs: repaglinide, nateglinide (-glinide)
Use: reduce postprandial hyperglycemia, take with meals
Side effects: weight gain, hypoglycemia
Nateglinide (class, mechanism, use, side effects, drug interactions)
Class: insulin secretagogue (meglitinides)
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release (same as sulfonylureas but unrelated structure)
Use: reduce postprandial hyperglycemia, take with meals
Side effects: weight gain, hypoglycemia
Drug interactions:
Repaglinide (class, mechanism, use, side effects, drug interactions)
Class: insulin secretagogue (meglitinides)
Mechanism: block K+ channel to cause ß-cell depolarization and insulin release (same as sulfonylureas but unrelated structure)
Use: reduce postprandial hyperglycemia, take with meals
Side effects: weight gain, hypoglycemia
Drug interactions:
SGL2 Inhibitors (Drugs, mechanism, uses, side effects)
Drugs: canagliflozin, dapagliflozin, empagliflozin (-gliflozins)
Mechanism: inhibit kidney SGLT2, reducing glucose reabsorption, so excrete glucose in urine
Use: t2DM, not in ppl with renal impairment
Side effects: increase DKA risk, yeast infection, UTI, orthostatic HTN (due to osmotic diuresis–>HTN) and dizziness/fainting
Canagliflozin (Class, mechanism, uses, side effects)
Class: SGLT-2 Inhibitors
Mechanism: inhibit kidney SGLT2, reducing glucose reabsorption, so excrete glucose in urine
Use: t2DM, not in ppl with renal impairment
Side effects: increase DKA risk, yeast infection, UTI, orthostatic HTN (due to osmotic diuresis–>HTN) and dizziness/fainting
Dapagliflozin (Class, mechanism, uses, side effects)
Class: SGLT-2 Inhibitors
Mechanism: inhibit kidney SGLT2, reducing glucose reabsorption, so excrete glucose in urine
Use: t2DM, not in ppl with renal impairment
Side effects: increase DKA risk, yeast infection, UTI, orthostatic HTN (due to osmotic diuresis–>HTN) and dizziness/fainting
Dapagliflozin (Class, mechanism, uses, side effects)
Class: SGLT-2 Inhibitors
Mechanism: inhibit kidney SGLT2, reducing glucose reabsorption, so excrete glucose in urine
Use: t2DM, not in ppl with renal impairment
Side effects: increase DKA risk, yeast infection, UTI, orthostatic HTN (due to osmotic diuresis–>HTN) and dizziness/fainting
GLP-1 Agonists (Drugs, mechanism, use, side effects)
Drugs: Exenatide, liraglutide, lixisenatide, dulaglutide, albiglutide (-natides and -glutides)
Mechanism: incretin released after meals that stimulates insulin secretion, inhibits appetite and glucagon
Use: t2DM
Side effects: GI
Exenatide (Class, mechanism, use, side effects)
Class: GLP-1 Agonist
Mechanism: incretin released after meals that stimulates insulin secretion, inhibits appetite and glucagon
Use: t2DM
Side effects: GI
Liraglutide (Class, mechanism, use, side effects)
Class: GLP-1 Agonist
Mechanism: incretin released after meals that stimulates insulin secretion, inhibits appetite and glucagon
Use: t2DM
Side effects: GI
Lixisenatide (Class, mechanism, use, side effects)
Class: GLP-1 Agonist
Mechanism: incretin released after meals that stimulates insulin secretion, inhibits appetite and glucagon
Use: t2DM
Side effects: GI
Dulaglutide (Class, mechanism, use, side effects)
Class: GLP-1 Agonist
Mechanism: incretin released after meals that stimulates insulin secretion, inhibits appetite and glucagon
Use: t2DM
Side effects: GI